Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Servier Drug Risk Trial Suspended After Challenge, France 3 Says

May 21 (Bloomberg) -- Les Laboratoires Servier and its founder won their bid to suspend a trial over claims they hid the risks of a diabetes drug, when a judge ruled their constitutional challenge to the process was serious enough to merit a higher court’s review, France 3 reported today, citing the judge.

A procedural hearing is planned for Dec. 14 to reschedule the trial, pending the outcome of the constitutional review, France 3 said on its website.

To contact the reporter on this story: Heather Smith in Paris at hsmith26@bloomberg.net

To contact the editor responsible for this story: Anthony Aarons at aaarons@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.